Over the last five years, about 75% of novel drugs were approved in the U.S. before any other country and the FDA’s drug review program remains the gold standard for regulatory review and approval around the world.
Over the last five years, about 75% of novel drugs were approved in the U.S. before any other country and the FDA’s drug review program remains the gold standard for regulatory review and approval around the world.
